科学家发现为什么 Ozempic 和 Wegovy 减肥最终会趋于平稳
NIH 的新研究表明，索马鲁肽会在控制食欲的脑细胞内引发不同的反应，为为什么 GLP-1 减肥药对每个人的作用不同提供了新的见解。科学家们还发现了一种可能的方法来延长...
schedule
13:39
visibility
33 浏览
来源: Science Daily
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
newspaper
